Apple faces fresh ITC investigation over Apple Watch blood oxygen feature
Apple faces a new US International Trade Commission investigation over its redesigned blood oxygen feature, potentially impacting holiday sales. The probe questions if Apple's workaround, shifting calculations to iPhones, still infringes on Masimo's patents. This follows a $634 million verdict against Apple and a previous import ban, with the ITC expected to conclude its review by April 2026.
Apple faces a new US International Trade Commission investigation over its redesigned blood oxygen feature, potentially impacting holiday sales. The probe questions if Apple's workaround, shifting calculations to iPhones, still infringes on Masimo's patents. This follows a $634 million verdict against Apple and a previous import ban, with the ITC expected to conclude its review by April 2026.
